Orthobiologics

The first 30 patients received treatment in DiscGenics' first-in-human U.S. clinical study of IDCT injectable disc cell therapy for mild to...

Cellular Biomedicine launched a Phase II clinical trial for AlloJoin® allogenic mesenchymal progenitor cell therapy in the treatment of knee osteoarthritis....

Isto Biologics launched Influx Demineralized Bone Matrix Putty, a pre-hydrated graft that is ready to use directly out of the package....

Biogennix received FDA 510(k) clearance and commenced launch of Agilon collagen-enhanced bone graft material....

DiscGenics was granted Fast Track designation from FDA for its investigational cell therapy, IDCT, under evaluation in clinical trials in...

Bioventus is launching its single-injection DUROLANE SJ hyaluronic acid-based OA treatment and received expanded indications for DUROLANE in Australia and New...

Anika Therapeutics announced completion of the first human surgical procedure with the company's injectable HA-based therapy to treat bone voids and defects....

Camber Spine is offering SCYLLA, an allogeneic bone matrix product containing viable spine-derived cells that is complementary to its SPIRA® and ENZA®...

NanoFUSE Biologics is introducing its bioactive glass + DBM biologic in Panama....

NanoFUSE commenced market release of NanoSTRIP, a 100% bioactive glass synthetic biologic strip indicated for spine and orthopedic use....